Table 2. Description of ATL cases Case .... | American Society of Hematology

Table 2.

Description of ATL cases

Case	Age at ATL diagnosis, y	Time in cohort, y	Place of birth	Ethnic group	HIV serology	Observed HTLV-1 seroconversion	ATL subtype	Status (April 2018)	Survival time
1	26	5.6	Surinam	NM	Negative	No	Lymphoma	Dead	0 d
2	45	7.3	French Guiana	NM	Negative	No	Lymphoma	Unknown	Unknown
3	47	8.6	Surinam	NM	Negative	No	Lymphoma	Alive	>10 y
4	29	14.7	Surinam	NM	Negative	No	Acute	Dead	3.5 mo
5	54	15.7	Surinam	NM	Negative	No	Acute	Dead	4.6 mo
6	51	18.6	Surinam	NM	Negative	No	ND	Dead	6.6 mo
7	52	19.9	Surinam	NM	Negative	No	Acute	Dead	3.9 mo
8	39	21.4	Surinam	ND	Negative	No	Lymphoma	Dead	1.0 mo
9	59	25.8	Surinam	NM	Negative	No	Acute	Dead	0.1 mo

Case	Age at ATL diagnosis, y	Time in cohort, y	Place of birth	Ethnic group	HIV serology	Observed HTLV-1 seroconversion	ATL subtype	Status (April 2018)	Survival time
1	26	5.6	Surinam	NM	Negative	No	Lymphoma	Dead	0 d
2	45	7.3	French Guiana	NM	Negative	No	Lymphoma	Unknown	Unknown
3	47	8.6	Surinam	NM	Negative	No	Lymphoma	Alive	>10 y
4	29	14.7	Surinam	NM	Negative	No	Acute	Dead	3.5 mo
5	54	15.7	Surinam	NM	Negative	No	Acute	Dead	4.6 mo
6	51	18.6	Surinam	NM	Negative	No	ND	Dead	6.6 mo
7	52	19.9	Surinam	NM	Negative	No	Acute	Dead	3.9 mo
8	39	21.4	Surinam	ND	Negative	No	Lymphoma	Dead	1.0 mo
9	59	25.8	Surinam	NM	Negative	No	Acute	Dead	0.1 mo

ND, not determined; NM, Noir Marron.